BIO Vice Chair (and incoming CEO) John F. Crowley speaks at the Reagan-Udall…
Genetic Medicines’ Path to Scalability for Patients and Investors source
Opportunities for Financing Your Company Through Series B and Beyond source
Tackling Challenges in Oncology Drug Discovery and Development source
Connecting Investors and Patient Advocacy Groups: An Overview of Funding New Therapies…
Policy Outlook: Understanding the Environment for Pricing and Access to Medicines…
AI within Biopharma: Separating Value from Hype source